JP2009536627A5 - - Google Patents

Download PDF

Info

Publication number
JP2009536627A5
JP2009536627A5 JP2009508191A JP2009508191A JP2009536627A5 JP 2009536627 A5 JP2009536627 A5 JP 2009536627A5 JP 2009508191 A JP2009508191 A JP 2009508191A JP 2009508191 A JP2009508191 A JP 2009508191A JP 2009536627 A5 JP2009536627 A5 JP 2009536627A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
bond
alkylene
alkynylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009508191A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009536627A (ja
JP5277159B2 (ja
Filing date
Publication date
Priority claimed from DE102006021874A external-priority patent/DE102006021874B4/de
Application filed filed Critical
Publication of JP2009536627A publication Critical patent/JP2009536627A/ja
Publication of JP2009536627A5 publication Critical patent/JP2009536627A5/ja
Application granted granted Critical
Publication of JP5277159B2 publication Critical patent/JP5277159B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009508191A 2006-05-11 2007-04-30 ４，５−ジフェニル−ピリミジニルアミノ置換カルボン酸類、それらの製造方法及び医薬品としての使用 Expired - Fee Related JP5277159B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102006021874.4 2006-05-11
DE102006021874A DE102006021874B4 (de) 2006-05-11 2006-05-11 4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP2007/003804 WO2007131620A1 (de) 2006-05-11 2007-04-30 4,5-diphenyl-pyrimidinyl-amino substituierte carbonsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (3)

Publication Number Publication Date
JP2009536627A JP2009536627A (ja) 2009-10-15
JP2009536627A5 true JP2009536627A5 (enExample) 2013-05-16
JP5277159B2 JP5277159B2 (ja) 2013-08-28

Family

ID=38326940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009508191A Expired - Fee Related JP5277159B2 (ja) 2006-05-11 2007-04-30 ４，５−ジフェニル−ピリミジニルアミノ置換カルボン酸類、それらの製造方法及び医薬品としての使用

Country Status (17)

Country Link
US (1) US7713988B2 (enExample)
EP (1) EP2024340B1 (enExample)
JP (1) JP5277159B2 (enExample)
KR (1) KR20090006845A (enExample)
CN (1) CN101421251B (enExample)
AR (1) AR060992A1 (enExample)
AU (1) AU2007250211B2 (enExample)
BR (1) BRPI0711393A2 (enExample)
CA (1) CA2651657A1 (enExample)
DE (1) DE102006021874B4 (enExample)
IL (1) IL195177A0 (enExample)
MX (1) MX2008014101A (enExample)
MY (1) MY148096A (enExample)
NO (1) NO20085066L (enExample)
TW (1) TW200815366A (enExample)
UY (1) UY30339A1 (enExample)
WO (1) WO2007131620A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7465804B2 (en) 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
EP1924546A1 (en) 2005-09-14 2008-05-28 Amgen, Inc Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
US7687526B2 (en) 2006-09-07 2010-03-30 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
AU2007293028B2 (en) 2006-09-07 2012-05-31 Amgen Inc. Heterocyclic GPR40 modulators
CA2683751C (en) 2007-04-16 2013-01-08 Amgen Inc. Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
KR20100090249A (ko) 2007-10-10 2010-08-13 암젠 인크 치환된 비페닐 ｇｒｐ４０ 조절제
US8450522B2 (en) 2008-03-06 2013-05-28 Amgen Inc. Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
US8748462B2 (en) 2008-10-15 2014-06-10 Amgen Inc. Spirocyclic GPR40 modulators
MX2011006006A (es) * 2008-12-08 2011-09-08 Euroscreen Sa Compuestos, composicion farmaceutica y metodos para utilizarse en el tratamiento de trastornos metabolicos.
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011140190A1 (en) 2010-05-05 2011-11-10 Infinity Pharmaceuticals Tetrazolones as inhibitors of fatty acid synthase
US8450350B2 (en) 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
AU2011296737A1 (en) 2010-08-31 2013-04-11 Snu R&Db Foundation Use of the fetal reprogramming of a PPAR delta agonist
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2014064215A1 (en) 2012-10-24 2014-05-01 INSERM (Institut National de la Santé et de la Recherche Médicale) TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL
EP3076959B1 (en) 2013-12-04 2018-07-04 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
US10059667B2 (en) 2014-02-06 2018-08-28 Merck Sharp & Dohme Corp. Antidiabetic compounds
WO2016151018A1 (en) 2015-03-24 2016-09-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Method and pharmaceutical composition for use in the treatment of diabetes
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
KR102708681B1 (ko) 2018-02-13 2024-09-26 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
EP4600247A3 (en) 2018-04-19 2025-11-19 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
UA126421C2 (uk) 2018-07-13 2022-09-28 Гіліад Сайєнсіз, Інк. Інгібітори pd-1/pd-l1
US11236085B2 (en) 2018-10-24 2022-02-01 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1546115A4 (en) * 2002-09-27 2010-08-04 Merck Sharp & Dohme Substituted pyrimidines
US20040259887A1 (en) * 2003-06-18 2004-12-23 Pfizer Inc Cannabinoid receptor ligands and uses thereof
MXPA06012130A (es) * 2004-04-20 2007-01-31 Transtech Pharma Inc Derivados de tiazol y pirimidina substituidos como moduladores del receptor de melanocortina.
DE102004039789A1 (de) * 2004-08-16 2006-03-02 Sanofi-Aventis Deutschland Gmbh Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Similar Documents

Publication Publication Date Title
JP2009536626A5 (enExample)
JP2009536629A5 (enExample)
Soare et al. Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis
RU2008148838A (ru) Фениламинобензоксазолзамещенные карбоновые кислоты, способ их получения и их применение в качестве лекарственных средств
Huang et al. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro
Huang et al. ER stress, the unfolded protein response and osteoclastogenesis: a review
JP2005501861A5 (enExample)
RU2010115748A (ru) (карбоксилалкиленфенил) фенилоксаламиды, способ их получения и их применение в качестве лекарственного средства
Lin et al. Growth hormone receptor mutations related to individual dwarfism
Shams et al. The pathophysiology of osteoporosis after spinal cord injury
Pei et al. Fluoride decreased osteoclastic bone resorption through the inhibition of NFATc1 gene expression
RU2008105756A (ru) Производные 1,4-бензотиазепин-1,1-диоксида, способ их получения, лекарственное средство, содержащее эти соединения и их применение в качестве гиполипидемических средств
RU2009122470A (ru) Новые бензилзамещенные производные 1,4-бензотиепин-1,1-диоксида, способ их получения, лекарственные средства, содержащие такие соединения, и их применение
JP2000509395A (ja) 無機イオン活性化合物
RU2009108280A (ru) Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение
Kim et al. Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression
JP2006502247A5 (enExample)
RU2007142657A (ru) Производные азола в качестве ингибиторов липаз и фосфолипаз
JP2007500145A5 (enExample)
JP2008536884A5 (enExample)
CN101090895A (zh) 芳基磺酰胺调节剂
Kruse et al. Novel insights into M3 muscarinic acetylcholine receptor physiology and structure
Tong et al. A review of signaling transduction mechanisms in osteoclastogenesis regulation by autophagy, inflammation, and immunity
Okita et al. Supplementation of strontium to a chondrogenic medium promotes chondrogenic differentiation of human dedifferentiated fat cells
CN101410384A (zh) 调节蛋白质运输的化合物和方法